Mrs Brenda G St Clair, LPN | |
490 Broadmoor Dr, Brinkley, AR 72021-2057 | |
(870) 734-3202 | |
(870) 734-3299 |
Full Name | Mrs Brenda G St Clair |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 490 Broadmoor Dr, Brinkley, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760040885 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | L42004 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Brenda G St Clair, LPN 2707 Browns Ln, Jonesboro, AR 72401-7213 Ph: (870) 972-4939 | Mrs Brenda G St Clair, LPN 490 Broadmoor Dr, Brinkley, AR 72021-2057 Ph: (870) 734-3202 |
News Archive
Research from the University of Kent predicts an end to deregulated competitive pubic transport in the UK as a consequence of Covid-19 social distancing measures leading to drastically reduced ridership, requiring a major rethinking of the provision of public transport.
A research team has discovered a protein without which cells infected by viruses cannot trigger an immune response, leading to 100% mortality with even non-disease-producing strains. The discovery of the new Z-DNA binding protein, or ZBP1, was reported in the journal Frontiers in Microbiology. It could help develop new treatment methods for viruses that target the nervous system such as the Zika or West Nile Encephalitis virus.
Cortex Pharmaceuticals, Inc. announced that it had been notified by Les Laboratoires Servier ("Servier"), France's largest privately held pharmaceutical company, of their intent to move forward into Phase I clinical studies with the jointly-discovered High Impact AMPAKINE® compound S47445 (CX1632).
Canada's cancer care system is not meeting the unique needs of young cancer patients. Adolescent and young adult (AYA) cancer patients and survivors often 'fall through the cracks' of a system that focuses on cancer in children or adults, but does not provide specialized care for this in-between group. To understand why and develop solutions, an international group of young survivors and cancer specialists will come together in Toronto.
› Verified 9 days ago